Dilsad Herkiloglu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dilsad Herkiloglu has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Ozge Cevik
Department of Biochemistry, Aydin Adnan Menderes University, School of Medicine, Aydin 09010, Turkey
3 shared publicationsSefik Gokce
Department of Obstetrics and Gynecology, Yeni Yuzyil University, School of Medicine, Gaziosmanpasa Hospital, Istanbul 34245, Turkey
3 shared publications- Şefik Gökçe
Department of Obstetrics and Gynecology, Gaziosmanpasa Hospital of Yeni Yuzyil University, Istanbul, Turkey
3 shared publications - Canan Kabaca
Department of Obstetrics and Gynecology, Zeynep Kamil Women and Children Diseases Education and Research Hospital, Uskudar, Istanbul, Turkey
2 shared publications Erkan Gumus
Department of Histology and Embryology, Aydin Adnan Menderes University, School of Medicine, Aydin 09010, Turkey
2 shared publicationsOmer Erdogan
Department of Biochemistry, Aydin Adnan Menderes University, School of Medicine, Aydin 09010, Turkey
2 shared publications
Latest Publications
- Open Access
- 1 January 2024
- Published by Turkiye Klinikleri in Journal of Reconstructive Urology
- Vol. 14 (1) , 1-10
Uropathogens According to the Trimesters, and Their Effects on Pregnancy Outcomes: A Retrospective Clinical Study
Objective: The present study aimed to examine the relationship between gestational urinary tract infection (UTI) cases and pregnancy complications such as preterm delivery and/or low birth weight, and to address the possible increase in risk from these aspects. Material and Methods: Seventy-one pregnant women who were diagnosed with UTI, and 102 healthy pregnant women were included in the study. Gestational week, delivery week, delivery method and newborns's birth weight data of women with positive urine culture were compared. Results: The median week of delivery was found to be significantly higher in those who had a UTI in the first trimester compared to those who had a UTI in the next trimester (p=0.005). The median week of gestation was significantly higher in those with Gram-positive bacterial growth than those with other microorganisms (p=0.006). Median gestational week was found to be significantly lower in those with Gram-negative bacteria growth than in those with growth of other microorganisms [15 (interquartile range: 15) weeks vs. 25.5 (IQR:13) weeks] (p=0.008). The median week of gestation in those with E. coli growth was found to be significantly lower than in those with other microorganism growth [8 (interquartile range: 14) weeks vs. 25 (interquartile span: 17) weeks] (p=0.013). The groups were similar in terms of preterm birth (p=0.799) and low birth weight (p=0.347). Conclusion: These findings show that UTI during pregnancy, particularly after the first trimester, may be associated with preterm delivery. It was also observed that the risk of preterm delivery significantly increased in pregnant women over the age of 35 and development of UTI after the first trimester.
- 1 January 2024
- Published by Turkiye Klinikleri in Journal of Reconstructive Urology
- Vol. 14 (1) , 1-10
Open AccessUropathogens According to the Trimesters, and Their Effects on Pregnancy Outcomes: A Retrospective Clinical Study
Objective: The present study aimed to examine the relationship between gestational urinary tract infection (UTI) cases and pregnancy complications such as preterm delivery and/or low birth weight, and to address the possible increase in risk from these aspects. Material and Methods: Seventy-one pregnant women who were diagnosed with UTI, and 102 healthy pregnant women were included in the study. Gestational week, delivery week, delivery method and newborns's birth weight data of women with positive urine culture were compared. Results: The median week of delivery was found to be significantly higher in those who had a UTI in the first trimester compared to those who had a UTI in the next trimester (p=0.005). The median week of gestation was significantly higher in those with Gram-positive bacterial growth than those with other microorganisms (p=0.006). Median gestational week was found to be significantly lower in those with Gram-negative bacteria growth than in those with growth of other microorganisms [15 (interquartile range: 15) weeks vs. 25.5 (IQR:13) weeks] (p=0.008). The median week of gestation in those with E. coli growth was found to be significantly lower than in those with other microorganism growth [8 (interquartile range: 14) weeks vs. 25 (interquartile span: 17) weeks] (p=0.013). The groups were similar in terms of preterm birth (p=0.799) and low birth weight (p=0.347). Conclusion: These findings show that UTI during pregnancy, particularly after the first trimester, may be associated with preterm delivery. It was also observed that the risk of preterm delivery significantly increased in pregnant women over the age of 35 and development of UTI after the first trimester.
- Open Access
- 1 January 2024
- Published by CSIR-National Institute of Science Communication and Policy Research (NIScPR) in Indian Journal of Biochemistry and Biophysics
- Vol. 61 (5) , 259-268
Functional relationship of Interferon regulator factor-5, Interferon-γ, and Hypoxia-induced factor-1α with COVID-19 during Pregnancy
Interferon-gamma (IFN-γ), interferon regulator factor-5 (IRF-5), and hypoxia-induced factor-1 alpha (HIF-1α) are amongst the key immune regulators that function in Coronavirus Disease 2019 (COVID-19).In most cases level of these markers significantly change in COVID-19 cases, especially in more severe cases. In addition, pregnancy itself shows more different immunological processes. So, we aimed to investigate the levels of IFN-γ, IRF-5, and HIF-1α in cases who had COVID-19 during their pregnancy. Thirty-three unvaccinated pregnant women with COVID-19, and 129 unvaccinated healthy pregnant women (control) were included in the study. IFN-γ, IRF-5, and HIF-1α levels were investigated in blood samples taken from pregnant women and newborns, and in tissue samples of placenta. Mean IFN-γ and IRF-5 levels in pregnant women with COVID-19 were significantly lower, whereas mean HIF-1α levels were significantly higher than the controls (P< 0.001, for each). In the receiver operating characteristic (ROC) analyses of maternal samples for determination of post-COVID-19 infection; the cutoff value of 2.015 ng/mg protein for IRF-5 level had a sensitivity of 81.8% and a specificity of 82.5% [area under the ROC curve (AUC): 0.161; P< 0.001; lower bound (LB): 0.08; upper bound (UB): 0.241; confidence interval (CI) 95%)], and the cutoff value of 225.63 pg/mg protein for IFN-γ level had a sensitivity of 81.8% and a specificity of 85.7% (AUC: 0.147; P< 0.001; LB:0.08; UB: 0.241; CI 95%). Our findings show that COVID-19 has a significant effect on IFN-γ, IRF-5, and HIF-1α levels in pregnant women, and thus these levels can be used as a reliable biomarker for the diagnosis of COVID-19 in pregnant women.
- 1 January 2024
- Published by CSIR-National Institute of Science Communication and Policy Research (NIScPR) in Indian Journal of Biochemistry and Biophysics
- Vol. 61 (5) , 259-268
Open AccessFunctional relationship of Interferon regulator factor-5, Interferon-γ, and Hypoxia-induced factor-1α with COVID-19 during Pregnancy
Interferon-gamma (IFN-γ), interferon regulator factor-5 (IRF-5), and hypoxia-induced factor-1 alpha (HIF-1α) are amongst the key immune regulators that function in Coronavirus Disease 2019 (COVID-19).In most cases level of these markers significantly change in COVID-19 cases, especially in more severe cases. In addition, pregnancy itself shows more different immunological processes. So, we aimed to investigate the levels of IFN-γ, IRF-5, and HIF-1α in cases who had COVID-19 during their pregnancy. Thirty-three unvaccinated pregnant women with COVID-19, and 129 unvaccinated healthy pregnant women (control) were included in the study. IFN-γ, IRF-5, and HIF-1α levels were investigated in blood samples taken from pregnant women and newborns, and in tissue samples of placenta. Mean IFN-γ and IRF-5 levels in pregnant women with COVID-19 were significantly lower, whereas mean HIF-1α levels were significantly higher than the controls (P< 0.001, for each). In the receiver operating characteristic (ROC) analyses of maternal samples for determination of post-COVID-19 infection; the cutoff value of 2.015 ng/mg protein for IRF-5 level had a sensitivity of 81.8% and a specificity of 82.5% [area under the ROC curve (AUC): 0.161; P< 0.001; lower bound (LB): 0.08; upper bound (UB): 0.241; confidence interval (CI) 95%)], and the cutoff value of 225.63 pg/mg protein for IFN-γ level had a sensitivity of 81.8% and a specificity of 85.7% (AUC: 0.147; P< 0.001; LB:0.08; UB: 0.241; CI 95%). Our findings show that COVID-19 has a significant effect on IFN-γ, IRF-5, and HIF-1α levels in pregnant women, and thus these levels can be used as a reliable biomarker for the diagnosis of COVID-19 in pregnant women.
- 25 August 2022
- Published by Galenos Yayinevi in Journal of Academic Research in Medicine
- Vol. 12 (2) , 49-54
A New Questionnaire for Aesthetic Gynecology: A Selfappraisal Questionnaire for Female Genital Cosmetic Procedure Demand (Q-FGCP)
- 25 August 2022
- Published by Galenos Yayinevi in Journal of Academic Research in Medicine
- Vol. 12 (2) , 49-54
A New Questionnaire for Aesthetic Gynecology: A Selfappraisal Questionnaire for Female Genital Cosmetic Procedure Demand (Q-FGCP)
- Open Access
- 17 May 2022
- Published by Spandidos Publications in Oncology Letters
- Vol. 24 (1) , 1-6
Expression of periostin according to endometrial cancer grade
While various molecular profiling methods have been described for the early diagnosis and prognostic process of endometrial cancer, the most common gynaecological cancer, the data obtained remain insufficient. The present study aimed to investigate the protein and gene expression of periostin and its role as a new biomarker in the diagnosis, treatment and prognosis of endometrial cancer. A total of 15 patients diagnosed with endometrial cancer at the Department of Pathology, Zeynep Kamil Training and Research Hospital (Istanbul, Turkey) and 15 patients who were operated on for non‑tumour‑related reasons, between December 2019 and May 2020, were included in the study. The cases diagnosed with endometrial cancer were divided into three groups: International Federation of Gynaecology and Obstetrics grades I, II and III. Pathology tumour blocks were selected for enzyme‑linked immunosorbent assay and PCR studies in which periostin gene expression and protein levels were measured, respectively. A significant increase in periostin gene expression was observed in the endometrial cancer samples compared with that in the controls (3.40±0.66 vs. 2.23±0.47). The protein level of periostin in the tissues was found to be higher in the endometrial cancer samples than that in the control group (1.59±0.31 vs. 0.94±0.22). The levels of periostin protein and gene expression detected in the endometrial cancer samples increased as the grade increased. To the best of our knowledge, the current study is the first to determine the levels of periostin protein and gene expression in endometrial cancer. The results suggested that periostin may be used as a biomarker in the determination of higher histological grade in endometrial cancer.
- 17 May 2022
- Published by Spandidos Publications in Oncology Letters
- Vol. 24 (1) , 1-6
Open AccessExpression of periostin according to endometrial cancer grade
While various molecular profiling methods have been described for the early diagnosis and prognostic process of endometrial cancer, the most common gynaecological cancer, the data obtained remain insufficient. The present study aimed to investigate the protein and gene expression of periostin and its role as a new biomarker in the diagnosis, treatment and prognosis of endometrial cancer. A total of 15 patients diagnosed with endometrial cancer at the Department of Pathology, Zeynep Kamil Training and Research Hospital (Istanbul, Turkey) and 15 patients who were operated on for non‑tumour‑related reasons, between December 2019 and May 2020, were included in the study. The cases diagnosed with endometrial cancer were divided into three groups: International Federation of Gynaecology and Obstetrics grades I, II and III. Pathology tumour blocks were selected for enzyme‑linked immunosorbent assay and PCR studies in which periostin gene expression and protein levels were measured, respectively. A significant increase in periostin gene expression was observed in the endometrial cancer samples compared with that in the controls (3.40±0.66 vs. 2.23±0.47). The protein level of periostin in the tissues was found to be higher in the endometrial cancer samples than that in the control group (1.59±0.31 vs. 0.94±0.22). The levels of periostin protein and gene expression detected in the endometrial cancer samples increased as the grade increased. To the best of our knowledge, the current study is the first to determine the levels of periostin protein and gene expression in endometrial cancer. The results suggested that periostin may be used as a biomarker in the determination of higher histological grade in endometrial cancer.
- Open Access
- 22 March 2022
- Published by Springer Nature in Research Square
Functional Relationship of Interferon Regulator Factor-5, Interferon-γ, and Hypoxia-Induced Factor-1α with COVID-19 During Pregnancy Outcomes
Objective: Interferon-gamma (IFN-γ), interferon regulator factor-5 (IRF5), and hypoxia-induced factor-1 Alpha (HIF-1α) are amongst the key immune molecules that function in Coronavirus Disease 2019 (COVID-19). Herein, we aimed to investigate the levels of IFN-γ, IRF5, and HIF-1α in cases who had COVID-19 during their pregnancy.Methods: Thirty-three unvaccinated pregnant women with COVID-19, and 129 unvaccinated healthy pregnant women (control) were included in the study. IRF5, IFN-γ, and HIF-1α levels were investigated in blood samples taken from pregnants and newborns, and in tissue samples of placenta.Results: Mean IRF5 and IFN-γ levels in pregnant women with COVID-19 were significantly lower, whereas mean HIF-1α levels were significantly higher than the controls (ppConclusion: Our findings show that COVID-19 has a significant effect on IRF5, IFN-γ and HIF-1α levels in pregnant women, and thus these levels can be used as a reliable biomarker for the diagnosis of COVID-19 in pregnant women. To the best of our knowledge, the present study is first attempt to evaluate the funational implications of these immunoregulatory biomarkers in pregnant women with COVID-19.
- 22 March 2022
- Published by Springer Nature in Research Square
Open AccessFunctional Relationship of Interferon Regulator Factor-5, Interferon-γ, and Hypoxia-Induced Factor-1α with COVID-19 During Pregnancy Outcomes
Objective: Interferon-gamma (IFN-γ), interferon regulator factor-5 (IRF5), and hypoxia-induced factor-1 Alpha (HIF-1α) are amongst the key immune molecules that function in Coronavirus Disease 2019 (COVID-19). Herein, we aimed to investigate the levels of IFN-γ, IRF5, and HIF-1α in cases who had COVID-19 during their pregnancy.Methods: Thirty-three unvaccinated pregnant women with COVID-19, and 129 unvaccinated healthy pregnant women (control) were included in the study. IRF5, IFN-γ, and HIF-1α levels were investigated in blood samples taken from pregnants and newborns, and in tissue samples of placenta.Results: Mean IRF5 and IFN-γ levels in pregnant women with COVID-19 were significantly lower, whereas mean HIF-1α levels were significantly higher than the controls (ppConclusion: Our findings show that COVID-19 has a significant effect on IRF5, IFN-γ and HIF-1α levels in pregnant women, and thus these levels can be used as a reliable biomarker for the diagnosis of COVID-19 in pregnant women. To the best of our knowledge, the present study is first attempt to evaluate the funational implications of these immunoregulatory biomarkers in pregnant women with COVID-19.
- 15 January 2022
- Published by Cagdas Tip Dergisi: Journal of Contemporary Medicine in Journal of Contemporary Medicine
- Vol. 12 (1) , 14-18
Depression and Anxiety Disorders in Patients with Hyperemesis Gravidarum and the Effect of This Disease on the Quality of Life
Background: Hyperemesis gravidarum can lead to depression or anxiety disorder in pregnant women more frequently than serious complications. This situation can significantly deteriorate the quality of life of the pregnant woman. In our study, it was aimed to investigate the levels of depression and anxiety in patients with hyperemesis gravidarum, and to analyze the effect of hyperemesis on quality of life. Materials and Methods: The study included 87 patients diagnosed with hyperemesis and 24 patients without hyperemesis admitted to our hospital between the dates of 01.04.2018-01.10.2018. All participants received Beck Anxiety Inventory, Beck Depression Inventory and 12-question quality of life (SF-12) forms. Results: The mean age of the patients included in the study was 25.4±5.0 years (Age range: 17-39 years). Minimal minimal anxiety and depression were detected in all participants. There was no significant difference between the group of patients diagnosed with hyperemesis and the control group in terms of mean depression score (p=0.161) and anxiety score (p=0.266). No significant difference was found in terms of the distribution of depression and anxiety levels between the groups (p=0.46 and p=0.557, respectively). Conclusion: In conclusion, our findings show that anxiety and depression levels cannot be directly correlated with hyperemesis gravidarum. However, it is necessary to closely monitor the psychological status of pregnant women diagnosed with hyperemesis, to perform the necessary supportive treatments and to improve their quality of life.
- 15 January 2022
- Published by Cagdas Tip Dergisi: Journal of Contemporary Medicine in Journal of Contemporary Medicine
- Vol. 12 (1) , 14-18
Depression and Anxiety Disorders in Patients with Hyperemesis Gravidarum and the Effect of This Disease on the Quality of Life
Background: Hyperemesis gravidarum can lead to depression or anxiety disorder in pregnant women more frequently than serious complications. This situation can significantly deteriorate the quality of life of the pregnant woman. In our study, it was aimed to investigate the levels of depression and anxiety in patients with hyperemesis gravidarum, and to analyze the effect of hyperemesis on quality of life. Materials and Methods: The study included 87 patients diagnosed with hyperemesis and 24 patients without hyperemesis admitted to our hospital between the dates of 01.04.2018-01.10.2018. All participants received Beck Anxiety Inventory, Beck Depression Inventory and 12-question quality of life (SF-12) forms. Results: The mean age of the patients included in the study was 25.4±5.0 years (Age range: 17-39 years). Minimal minimal anxiety and depression were detected in all participants. There was no significant difference between the group of patients diagnosed with hyperemesis and the control group in terms of mean depression score (p=0.161) and anxiety score (p=0.266). No significant difference was found in terms of the distribution of depression and anxiety levels between the groups (p=0.46 and p=0.557, respectively). Conclusion: In conclusion, our findings show that anxiety and depression levels cannot be directly correlated with hyperemesis gravidarum. However, it is necessary to closely monitor the psychological status of pregnant women diagnosed with hyperemesis, to perform the necessary supportive treatments and to improve their quality of life.
- Open Access
- 5 September 2021
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 4 (5) , 526-531
Cardiovascular risk factors in polycystic ovary syndrome; the relationship of dyslipidemia and obesity
Aim: The abnormal endocrinological picture that occurs in polycystic ovary syndrome (PCOS) has been shown to affect many systems and can lead to a wide variety of complications. In our study, it was aimed to examine hormone levels, obesity, serum lipid levels and hematological parameters in adult women with PCOS. Material and Methods: The present study included 62 patients diagnosed with PCOS and 45 healthy women. Demographic data and laboratory results of all women were collected them from hospital automation system records and were analyzed. Results: The mean body mass index (BMI) (p=0.041), total cholesterol (p=0.038), triglyceride (p=0.022) and very low density lipoprotein (VLDL) cholesterol (p=0.003) levels in the patient group were significantly higher than the control group. In the patient group, anti-Müllerian hormon (AMH) (p
- 5 September 2021
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 4 (5) , 526-531
Open AccessCardiovascular risk factors in polycystic ovary syndrome; the relationship of dyslipidemia and obesity
Aim: The abnormal endocrinological picture that occurs in polycystic ovary syndrome (PCOS) has been shown to affect many systems and can lead to a wide variety of complications. In our study, it was aimed to examine hormone levels, obesity, serum lipid levels and hematological parameters in adult women with PCOS. Material and Methods: The present study included 62 patients diagnosed with PCOS and 45 healthy women. Demographic data and laboratory results of all women were collected them from hospital automation system records and were analyzed. Results: The mean body mass index (BMI) (p=0.041), total cholesterol (p=0.038), triglyceride (p=0.022) and very low density lipoprotein (VLDL) cholesterol (p=0.003) levels in the patient group were significantly higher than the control group. In the patient group, anti-Müllerian hormon (AMH) (p
- 30 August 2021
- Published by VM Media Group sp. z o.o in Ginekologia Polska
- Vol. 92 (8) , 537-543
Correlation of monocyte/HDL ratio (MHR) with inflammatory parameters in obese patients diagnosed with polycystic ovary syndrome
Objectives: Monocyte/high density lipprotein (HDL) ratio (MHR) has been reported to be associated with obesity and polycystic ovarian syndrome (PCOS). In this study, it was aimed to evaluate whether there is a relationship between PCOS and MHR and inflammatory parameters, to investigate the relationship level of MHR and lymphocyte/monocyte ratio (LMR), which are easily accessible inflammatory and oxidative stress markers, with obese women with PCOS, and to determine the usability of MHR as a predictive marker for PCOS. Material and methods: The study included 64 PCOS-patients who were admitted to Gynecology clinics and 52 healthy women. The mean MHR (12.5 ± 4.6) in the PCOS group was significantly higher than the control group (10.4 ± 4.0) (p = 0.01). In the examination performed by combining the groups PCOS and obesity status, the mean MHR value in the PCOS-obese group was significantly higher than all the other groups (p = 0.004). In the ROC analysis, the threshold value of 10.1 for MHR was found to have a sensitivity of 84.8% and specificity of 58.5% in determining the association between PCOS and obesity (AUC: 0.721; p < 0.001; LB: 0.628; UB: 0.814; CI 95%). Accordingly, the rate of those with MHR level of 10.1 and above was significantly higher in the PCOS group compared to the control group (67.2% vs 40.4%) (p = 0.001). In the logistic regression analysis, the determination is increased by 3,026 times (odds ratio; 1.401–6.535) in predicting the presence of PCOS in those with MHR value of 10.1 and above, and 7,576 times (Odds ratio; 2.652–21.646) in predicting the presence of PCOS + obesity. was found to be. Correlation analysis in PCOS patients revealed that the MHR value was negatively correlated with age (p = 0.001; r = –0.412), LMR (p = 0.003; r = –0.377), and total cholesterol [p = 0.018; correlation coefficient (r) = –0.302]. Conclusions: This study findings showed that MHR level is significantly related to PCOS, and especially MHR values above 10.1 may be a significant predictive marker for PCOS. Our study findings also show that an association of PCOS and obesity is a very important trigger on MHR. Objectives: Monocyte/high density lipprotein (HDL) ratio (MHR) has been reported to be associated with obesity and polycystic ovarian syndrome (PCOS). In this study, it was aimed to evaluate whether there is a relationship between PCOS and MHR and inflammatory parameters, to investigate the relationship level of MHR and lymphocyte/monocyte ratio (LMR), which are easily accessible inflammatory and oxidative stress markers, with obese women with PCOS, and to determine the usability of MHR as a predictive marker for PCOS. Material and methods: The study included 64 PCOS-patients who were admitted to Gynecology clinics and 52 healthy women. The mean MHR (12.5 ± 4.6) in the PCOS group was significantly higher than the control group (10.4 ± 4.0) (p = 0.01). In the examination performed by combining the groups PCOS and obesity status, the mean MHR value in the PCOS-obese group was significantly higher than all the other groups (p = 0.004). In the ROC analysis, the threshold value of 10.1 for MHR was found to have a sensitivity of 84.8% and specificity of 58.5% in determining the association between PCOS and obesity (AUC: 0.721; p < 0.001; LB: 0.628; UB: 0.814; CI 95%). Accordingly, the rate of those with MHR level of 10.1 and above was significantly higher in the PCOS group compared to the control group (67.2% vs 40.4%) (p = 0.001). In the logistic regression analysis, the determination is increased by 3,026 times (odds ratio; 1.401–6.535) in predicting the presence of PCOS in those with MHR value of 10.1 and above, and 7,576 times (Odds ratio; 2.652–21.646) in predicting the presence of PCOS + obesity. was found to be. Correlation analysis in PCOS patients revealed that the MHR value was negatively correlated with age (p = 0.001; r = –0.412), LMR (p = 0.003; r = –0.377), and total cholesterol [p = 0.018; correlation coefficient (r) = –0.302]. Conclusions: This study findings showed that MHR level is significantly related to PCOS, and especially MHR values above 10.1 may be a significant predictive marker for PCOS. Our study findings also show that an association of PCOS and obesity is a very important trigger on MHR.
- 30 August 2021
- Published by VM Media Group sp. z o.o in Ginekologia Polska
- Vol. 92 (8) , 537-543
Correlation of monocyte/HDL ratio (MHR) with inflammatory parameters in obese patients diagnosed with polycystic ovary syndrome
Objectives: Monocyte/high density lipprotein (HDL) ratio (MHR) has been reported to be associated with obesity and polycystic ovarian syndrome (PCOS). In this study, it was aimed to evaluate whether there is a relationship between PCOS and MHR and inflammatory parameters, to investigate the relationship level of MHR and lymphocyte/monocyte ratio (LMR), which are easily accessible inflammatory and oxidative stress markers, with obese women with PCOS, and to determine the usability of MHR as a predictive marker for PCOS. Material and methods: The study included 64 PCOS-patients who were admitted to Gynecology clinics and 52 healthy women. The mean MHR (12.5 ± 4.6) in the PCOS group was significantly higher than the control group (10.4 ± 4.0) (p = 0.01). In the examination performed by combining the groups PCOS and obesity status, the mean MHR value in the PCOS-obese group was significantly higher than all the other groups (p = 0.004). In the ROC analysis, the threshold value of 10.1 for MHR was found to have a sensitivity of 84.8% and specificity of 58.5% in determining the association between PCOS and obesity (AUC: 0.721; p < 0.001; LB: 0.628; UB: 0.814; CI 95%). Accordingly, the rate of those with MHR level of 10.1 and above was significantly higher in the PCOS group compared to the control group (67.2% vs 40.4%) (p = 0.001). In the logistic regression analysis, the determination is increased by 3,026 times (odds ratio; 1.401–6.535) in predicting the presence of PCOS in those with MHR value of 10.1 and above, and 7,576 times (Odds ratio; 2.652–21.646) in predicting the presence of PCOS + obesity. was found to be. Correlation analysis in PCOS patients revealed that the MHR value was negatively correlated with age (p = 0.001; r = –0.412), LMR (p = 0.003; r = –0.377), and total cholesterol [p = 0.018; correlation coefficient (r) = –0.302]. Conclusions: This study findings showed that MHR level is significantly related to PCOS, and especially MHR values above 10.1 may be a significant predictive marker for PCOS. Our study findings also show that an association of PCOS and obesity is a very important trigger on MHR. Objectives: Monocyte/high density lipprotein (HDL) ratio (MHR) has been reported to be associated with obesity and polycystic ovarian syndrome (PCOS). In this study, it was aimed to evaluate whether there is a relationship between PCOS and MHR and inflammatory parameters, to investigate the relationship level of MHR and lymphocyte/monocyte ratio (LMR), which are easily accessible inflammatory and oxidative stress markers, with obese women with PCOS, and to determine the usability of MHR as a predictive marker for PCOS. Material and methods: The study included 64 PCOS-patients who were admitted to Gynecology clinics and 52 healthy women. The mean MHR (12.5 ± 4.6) in the PCOS group was significantly higher than the control group (10.4 ± 4.0) (p = 0.01). In the examination performed by combining the groups PCOS and obesity status, the mean MHR value in the PCOS-obese group was significantly higher than all the other groups (p = 0.004). In the ROC analysis, the threshold value of 10.1 for MHR was found to have a sensitivity of 84.8% and specificity of 58.5% in determining the association between PCOS and obesity (AUC: 0.721; p < 0.001; LB: 0.628; UB: 0.814; CI 95%). Accordingly, the rate of those with MHR level of 10.1 and above was significantly higher in the PCOS group compared to the control group (67.2% vs 40.4%) (p = 0.001). In the logistic regression analysis, the determination is increased by 3,026 times (odds ratio; 1.401–6.535) in predicting the presence of PCOS in those with MHR value of 10.1 and above, and 7,576 times (Odds ratio; 2.652–21.646) in predicting the presence of PCOS + obesity. was found to be. Correlation analysis in PCOS patients revealed that the MHR value was negatively correlated with age (p = 0.001; r = –0.412), LMR (p = 0.003; r = –0.377), and total cholesterol [p = 0.018; correlation coefficient (r) = –0.302]. Conclusions: This study findings showed that MHR level is significantly related to PCOS, and especially MHR values above 10.1 may be a significant predictive marker for PCOS. Our study findings also show that an association of PCOS and obesity is a very important trigger on MHR.
- 21 January 2021
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 35 (10) , 1834-1840
Pessary use in patients diagnosed with short cervix and cervical insufficiency
The aim was to evaluate the effectiveness of Arabin pessary use in patients with cervical insufficiency or short cervix before the 24th week of gestation and the impact of cervical examination find...
- 21 January 2021
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 35 (10) , 1834-1840
Pessary use in patients diagnosed with short cervix and cervical insufficiency
The aim was to evaluate the effectiveness of Arabin pessary use in patients with cervical insufficiency or short cervix before the 24th week of gestation and the impact of cervical examination find...
- 1 December 2020
- Published by Galenos Yayinevi in Journal of Academic Research in Medicine
- Vol. 10 (3) , 283-287
Relationship of Endometrial Polyp Prediction with Clinical and Demographic Findings
- 1 December 2020
- Published by Galenos Yayinevi in Journal of Academic Research in Medicine
- Vol. 10 (3) , 283-287
Relationship of Endometrial Polyp Prediction with Clinical and Demographic Findings